Updated:
Avant Bio
AVANT BIO partners with visionaries at the intersection of advanced technologies and novel therapeutics, investing in companies delivering cutting-edge...
Overview
AVANT BIO partners with visionaries at the intersection of advanced technologies and novel therapeutics, investing in companies delivering cutting-edge technologies to advance game-changing therapeutics. The firm focuses on Therapeutic Enabling Technologies, Biomanufacturing Tools & Automation, Machine Learning and AI Applications, Healthtech, Techbio, and Contract Services. It actively partners with entrepreneurs to maximize value creation, providing connections, deep expertise, and long-term guidance.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Principals
Daniella Kranjac
Founding GP
Ole Henrik Bang-Andreasen
Partner
Sebastien Latapie
Partner
Maik W. Jornitz
Operating Advisor
Lukas Utiger
Operating Advisor
Peter Lee
Sector focus
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: